As further investigations are necessary to better understand the real role of purinergic signaling in the diseases here presented, we also propose a novel mechanistic perspective, in which purinergic receptors from glial cells are key initiators of motor dysfunction in PD, MS, ALS and other MND. This evidence concerns the gene P2RX1 and amyotrophic lateral sclerosis.